CLSI MM21
Genomic Copy Number Microarrays for Constitutional Genetic and Oncology Applications
inactive
Buy Now
| Organization: | CLSI |
| Publication Date: | 1 August 2015 |
| Status: | inactive |
| Page Count: | 50 |
scope:
This guideline provides recommendations for the appropriate
performance, validation or verification, and interpretation of
nucleic acid microarrays used primarily for cytogenetic
applications to measure copy number (CN) imbalances, traditional
array-based comparative genomic hybridization (aCGH), and single
nucleotide polymorphism (SNP) arrays for CN imbalances and absence
of heterozygosity (AOH). Both constitutional (prenatal/postnatal)
The intended users of this guideline are clinical genetics laboratorians who perform cytogenetics and molecular genetics testing.
This guideline:
- Is not intended for research laboratorians
- Is not intended to provide guidance to manufacturers
- Does not address methylation arrays, RNA expression microarrays, resequencing and genotyping arrays not intended for CN detection, microarrays for the diagnosis and monitoring of infectious diseases, or non-nucleic acid microarrays (eg, protein arrays)
Document History
August 1, 2015
Genomic Copy Number Microarrays for Constitutional Genetic and Oncology Applications
This guideline provides recommendations for the appropriate performance, validation or verification, and interpretation of nucleic acid microarrays used primarily for cytogenetic applications to...
CLSI MM21
August 1, 2015
Genomic Copy Number Microarrays for Constitutional Genetic and Oncology Applications
This guideline provides recommendations for the appropriate performance, validation or verification, and interpretation of nucleic acid microarrays used primarily for cytogenetic applications to...